How to Adjust Nicardipine Drip
Start nicardipine at 5 mg/hr IV and increase by 2.5 mg/hr every 5-15 minutes (every 5 minutes for rapid reduction, every 15 minutes for gradual reduction) up to a maximum of 15 mg/hr until target blood pressure is achieved. 1, 2
Initial Dosing Protocol
- Begin at 5 mg/hr IV infusion through a central line or large peripheral vein 2
- Titrate by 2.5 mg/hr increments based on urgency 1, 2:
- Maximum dose is 15 mg/hr - this is an absolute ceiling regardless of clinical scenario 1, 3, 2
Blood Pressure Targets by Clinical Scenario
The target blood pressure varies dramatically by underlying condition - do not aim for normalization in most cases 1, 3:
- Hypertensive emergencies (general): Reduce mean arterial pressure by 10-15% in the first hour, not exceeding 25% reduction in 24 hours 4, 1, 3
- Acute ischemic stroke (pre-thrombolytic): Maintain BP <185/110 mmHg before rtPA administration 4, 1, 3
- Acute ischemic stroke (post-thrombolytic): Maintain BP <180-185 mmHg systolic and <105-110 mmHg diastolic 4, 1
- Acute hemorrhagic stroke: Target systolic BP 130-180 mmHg 4
- Malignant hypertension: Reduce mean arterial pressure by 20-25% over several hours 4
- Acute aortic dissection: Target systolic BP <120 mmHg 4
Monitoring Requirements
- During active titration: Check BP every 15 minutes 1, 3, 2
- Post-thrombolytic stroke patients: Monitor every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly for 16 hours 1, 3
- General severe hypertension: Monitor every 15 minutes during titration, then every 30 minutes once stable 1, 3
- Continuous cardiac monitoring is required throughout 1
Maintenance Dosing
- Once target BP is achieved, reduce to 3 mg/hr as maintenance dose 1, 2
- Continue monitoring at extended intervals as above 1
- Duration of action is 4-6 hours at constant infusion rate 1
- Offset occurs within 30-40 minutes after discontinuation 1
Downtitration Protocol
When blood pressure is controlled and you need to wean:
- Decrease by 2.5 mg/hr every 5-15 minutes while continuously monitoring BP 1
- Find the lowest effective maintenance rate that keeps BP at target 1
- Monitor BP every 15 minutes during downtitration, then extend to every 30 minutes for 6 hours once stable 1
- Transition to oral therapy should begin before discontinuing IV nicardipine - start oral agents and overlap appropriately 1
Managing Hypotension or Tachycardia
- Immediately discontinue the infusion if hypotension or tachycardia develops 2
- Once BP and heart rate stabilize, restart at 3-5 mg/hr and titrate more cautiously 1, 2
When Maximum Dose Fails
If BP remains uncontrolled at 15 mg/hr:
- Consider sodium nitroprusside for refractory hypertension 3
- Alternative: labetalol 10-20 mg IV bolus over 1-2 minutes, may repeat every 10-20 minutes up to 300 mg maximum 3
- Labetalol is contraindicated in heart block, bradycardia, decompensated heart failure, and reactive airways disease 5
Critical Safety Considerations
- Change infusion site every 12 hours if using peripheral vein to prevent phlebitis 2, 6
- Avoid small veins (dorsum of hand/wrist) - use large peripheral or central veins 2
- In cerebrovascular disease, avoid excessive BP reduction - maintain BP at higher end of acceptable ranges to preserve cerebral perfusion 1, 5
- Monitor closely in patients with congestive heart failure, hepatic impairment, or renal impairment 2
Important Drug Interactions
- Nicardipine inhibits CYP3A4 - significantly elevates cyclosporine and tacrolimus levels; monitor trough levels frequently 1, 5, 2
- Cimetidine increases nicardipine levels - use caution if co-administered 1, 5, 2
Common Pitfalls to Avoid
- Do not titrate too aggressively - precipitous BP drops can cause stroke or organ hypoperfusion in patients with chronic severe hypertension 4, 3
- Do not aim for normalization - target modest reductions (10-15% in first hour) unless specific scenarios require otherwise 1, 3
- Do not forget to change IV site - phlebitis develops after 12-14 hours at single site 2, 6
- Do not use in advanced aortic stenosis - this is a contraindication 2